Skip to content
Metrion Biosciences Logo Metrion Biosciences Logo
  • Home
  • Services
    • Ion Channel Screening
    • Cardiac Safety Screening
      • hERG Screening
    • Neuroscience
    • Translational Assays
      • Cardiac
      • Neuronal
    • Integrated Drug Discovery
  • About
    • History
    • Leadership Team
    • Board of Directors
    • Financial Reports
    • Corporate Presentations
  • Resources
    • Application Notes
    • White Papers
    • Flyers and Conference Material
    • Posters and Presentations
    • Recent Publications
    • Videos and Webinars
  • News & Events
    • Press Releases
    • Job Vacancies
    • Forthcoming Events
    • Past Events
    • Press Coverage
  • Blog
  • Contact us
    • Contact us
    • Get a Quote
    • Opt in to Metrion updates
  • Japanese

Press Releases

Home/Press Releases
Press ReleasesTony Rush2021-01-18T14:07:56+00:00

2021

18th January 2021: Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration.

2020

08th September 2020: Metrion Biosciences strengthens global business development team.

07th April 2020: Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines.

2019

3rd December 2019: Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research

8th April 2019: Metrion Biosciences appoints Dr Andrew Southan as Chief Executive Officer

1st April 2019: Metrion Biosciences closes funding round

29th January 2019: Metrion Biosciences and LifeArc sign collaboration agreement for neuroscience-focused ion channel drug discovery.

2018

17th September 2018: Metrion Biosciences makes senior appointments to strengthen its drug discovery leadership team 
05th September 2018: Metrion Biosciences and AMRI collaborate to offer ion channel drug discovery services.
28th August 2018: Metrion awarded £637k Innovate UK Biomedical Catalyst primer award.
05th March 2018: Metrion appoints two new Board Directors.
12th February 2018: Metrion Biosciences establishes Scientific Advisory Board.
5th February 2018: Metrion Biosciences awarded £200k funding under Innovate UK Biomedical Catalyst FeasibilityAward.
29th January 2018: Metrion Biosciences acquires rights to small molecule potassium channel inhibitors from Japan Tobacco Inc.
16th January 2018: Metrion Biosciences opens £600k investment round through SyndicateRoom to support growth of service business.

2017

31st July 2017: LifeArc and Metrion Biosciences extend partnership to support LifeArc’s neuroscience small molecule drug discovery programme.
2nd May 2017: Metrion Biosciences appoints Chief Operating Officer and Head of Business Development.
24th April 2017: Metrion Biosciences and Venomtech announce collaboration to search for novel modulators of ion channels with proven therapeutic potential.
15th March 2017: Metrion Biosciences and Concept Life Sciences Introduce Integrated Ion Channel Drug Discovery Service.

2016

7th November 2016: Axiogenesis and Metrion announce stem cell collaboration.
17th October 2016: Metrion Expands Operations.
23rd August 2016: Metrion Biosciences Joins CRACK IT “DRGNET” Human Pain Research Consortium.
26th July 2016: Axol Bioscience and Metrion Biosciences Announce Research Collaboration to Study Human Stem Cell-Derived Cardiomyocytes for Cardiac Safety and Drug Discovery Applications.
21st March 2016: Metrion Biosciences receives funding to work on human stem cell-derived iPS cardiomyocytes to create better cardiac safety assays.

2015

22nd October 2015: Metrion Biosciences becomes and independent CRO.
13th May 2015: Xention introduces Metrion Biosciences, a Specialist Ion Channel Screening Business.

Metrion Services

If you have a specific enquiry or would like to learn more about our capabilities and expertise please get in touch with the team

Contact


Explore

  • History
  • Services
  • Contact us

CONTACT INFOMATION

  • Suite 1, Riverside 3
    Granta Park
    Great Abington
    Cambridge
    CB21 6AD
  • +44 (0) 1223 919 100
  • info@metrionbiosciences.com
Map of Metrion location Cambridge Granta Park

Twitter

Social

Copyright Metrion Biosciences Privacy Policy
Douglass Digital | Cambridge Web Design
//
Go to Top